Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

Document first published:
Page updated:
Topic:
,
Publication type:

Instructions for the lead pharmacist and lead GP at the primary care network designated site to carry out risk assessments associated with the transfer of vaccine. The statement also sets out risk reduction measures which must be in place.

Link

Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

NHS England is not responsible for content on external websites.

Summary

Published 21 September 2021.

Document

Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

Position statement for reducing microbial risk when transporting COVID-19 vaccines in pop up, roving, and mobile models

  • PDF
  • 76 KB
  • 2 pages

Summary

Published 21 September 2021.